0001209191-20-039726.txt : 20200701 0001209191-20-039726.hdr.sgml : 20200701 20200701161616 ACCESSION NUMBER: 0001209191-20-039726 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200701 DATE AS OF CHANGE: 20200701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prener Anne CENTRAL INDEX KEY: 0001797917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38822 FILM NUMBER: 201005533 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS STREET 2: 399 BINNEY STREET SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kaleido Biosciences, Inc. CENTRAL INDEX KEY: 0001751299 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 617-674-9000 MAIL ADDRESS: STREET 1: 18 CROSBY DRIVE CITY: BEDFORD STATE: MA ZIP: 01730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-30 0 0001751299 Kaleido Biosciences, Inc. KLDO 0001797917 Prener Anne C/O KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVENUE LEXINGTON MA 02421 1 0 0 0 Stock Option (Right to Buy) 7.43 2020-06-30 4 A 0 15000 0.00 A 2021-06-30 2030-06-29 Common Stock 15000 15000 D /s/ Jerald Korn, Attorney-in-Fact 2020-07-01